Literature DB >> 18767118

The impact of margin status on local recurrence following breast conserving therapy for invasive carcinoma in Manitoba.

K Hardy1, K Fradette, R Gheorghe, L Lucman, S Latosinsky.   

Abstract

BACKGROUND: Histologically positive margins are generally considered unacceptable with breast conserving therapy (BCT) given the increased risk of local recurrence (LR). What constitutes an adequate negative margin remains controversial. Margin status was explored as a predictor of LR post-BCT.
METHODS: Manitoba women with loco-regional progression and/or mastectomy >6 months following BCT for Stage I/II invasive cancer (1995-2004) were identified from the Manitoba Cancer Registry; LR cases were confirmed by chart review. Three controls per case were matched by age, grade, stage, and adjuvant chemotherapy use. Margin status was categorized as histologically positive, < or =1 mm, < or =2 mm or >2 mm. Conditional logistic regression determined the odds ratio of LR by margin category.
RESULTS: There were 50 LR cases in 3,017 patients who underwent BCT, with a median follow-up of 60 months. Wider margins were associated with a non-significant reduction in LR: >1 mm versus < or =1 mm (OR 0.69; 95% CI 0.28-1.69) and >2 mm versus < or =2 mm (OR 0.90; 95% CI 0.44-1.84).
CONCLUSIONS: No clear benefit to wider histologically negative margins is demonstrated. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18767118     DOI: 10.1002/jso.21126

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Margins! Margins. Margins? How Important Is Margin Status in Breast-Preserving Therapy?

Authors:  Jürgen Dunst; Kathrin Dellas
Journal:  Breast Care (Basel)       Date:  2011-10-31       Impact factor: 2.860

2.  The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis.

Authors:  Nehmat Houssami; Petra Macaskill; M Luke Marinovich; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2014-01-29       Impact factor: 5.344

3.  Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis.

Authors:  Jeffrey J Sisler; Bosu Seo; Alan Katz; Emma Shu; Daniel Chateau; Piotr Czaykowski; Debrah Wirtzfeld; Harminder Singh; Donna Turner; Patricia Martens
Journal:  J Oncol Pract       Date:  2012-01-31       Impact factor: 3.840

4.  Margin Status Influence on the Outcome of Patients Treated with Breast Conserving Surgery.

Authors:  Akbari Me; M Akbari; H Zirakzadeh; N Nafissi; A Heidari; F Hosseinizadegan Shirazi
Journal:  Iran J Cancer Prev       Date:  2011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.